RecallRadar

FDA Drug recall D-1187-2022

Morphine Sulfate extended-Release Tablets, USP

On 2022-07-20 the FDA classified a Class I recall of Morphine Sulfate extended-Release Tablets, USP by Bryant Ranch Prepack, citing labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine….

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1187-2022
ClassificationClass I
Statusterminated
Initiated2022-06-17
Published2022-07-20
Last updated2026-09-13 11:52 UTC
CompanyBryant Ranch Prepack
DistributionAL

Product

Morphine Sulfate extended-Release Tablets, USP; 30 mg, 100-count bottles, Rx only, manufactured by: Ohm Laboratories Inc., New Brunswick NJ 08901 USA; Relabeled by: Bryant Ranch Prepack, Inc., Burbank, CA, 91504 USA, NDC: 63629-1088-01.

Reason

Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.

Identifiers

code_infoLot #: 179642, Exp. Date 11/30/2023.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1187-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.